These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9735866)

  • 21. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
    Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY
    J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Standardization of hemopoietic colony assay reagents].
    Ueda M; Takanashi M; Tsubokura M; Ide T; Iwai S; Okai M; Akaza T; Nakajima K; Tadokoro K; Juji T
    Rinsho Ketsueki; 1998 Sep; 39(9):625-30. PubMed ID: 9796394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial-like vascular progenitor cells (VPCs) from allogeneic and autologous donors: mobilization features distinct from hematopoietic progenitors.
    Allan DS; Dubé P; Roy J; Busque L; Roy DC
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):433-9. PubMed ID: 17382249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ex-vivo expansion of CFU-GM and BFU-E in unselected PBMC cultures with Flt3L is enhanced by autologous plasma.
    Guo M; Miller WM; Papoutsakis ET; Patel S; James C; Goolsby C; Winter JN
    Cytotherapy; 1999; 1(3):183-94. PubMed ID: 12881174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bovine erythroid (CFU-E, BFU-E) and granulocyte-macrophage colony formation in culture.
    Fritsch G; Nelson RT
    Exp Hematol; 1990 Mar; 18(3):195-200. PubMed ID: 2303113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor.
    Schwartzberg LS; Birch R; Hazelton B; Tauer KW; Lee P; Altemose R; George C; Blanco R; Wittlin F; Cohen J
    J Hematother; 1992; 1(4):317-27. PubMed ID: 1285381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Optimal methods for peripheral blood progenitor assay and its relevance in the blood cell autotransplantation].
    Ninomiya T; Takaue Y; Watanabe T; Azekawa S; Hirao A; Saito S; Abe T; Nakanishi J; Kawano Y; Kuroda Y
    Rinsho Ketsueki; 1990 Jan; 31(1):29-34. PubMed ID: 1968984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clonogenic potential of hematopoietic stem cells and mesenchymal stromal cells in various hematologic diseases: a pilot study.
    Kurt Yüksel M; Topçuoğlu P; Kurdal M; Ilhan O
    Cytotherapy; 2010; 12(1):38-44. PubMed ID: 19878078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
    Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
    Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mobilization of peripheral blood stem cells with paclitaxel and rhG-CSF in high-risk breast cancer patients.
    Meehan KR; Slack R; Gehan E; Herscowitz HB; Areman EM; Ebadi M; Cairo MS; Lippman ME
    J Hematother Stem Cell Res; 2002 Apr; 11(2):415-21. PubMed ID: 11983113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of in vitro characteristics of colony-forming cells in myelodysplastic syndrome and comparison with that in non-severe aplastic anemia].
    Zhang TJ; Feng M; Zheng YZ; Li XX; Xu ZF; Qin TJ; Zhang Y; Yang YB; Liu JX; Ren YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):516-21. PubMed ID: 22967409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of human bone marrow-derived stem cell colony formation (CFU-E, BFU-E, and CFU-GM) following in vitro exposure to organophosphates.
    Gallicchio VS; Casale GP; Watts T
    Exp Hematol; 1987 Dec; 15(11):1099-102. PubMed ID: 3678410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thawed autologous peripheral blood stem cells require modified quantification methods for hematopoietic progenitor cell evaluation.
    Decot V; Alla F; Latger-Cannard V; Visanica S; Witz B; Stoltz JF; Bensoussan D
    Biomed Mater Eng; 2012; 22(1-3):57-67. PubMed ID: 22766703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of a commercial kit for performing in vitro bone marrow cultures].
    Besson I; Marín P; Merino A; Urbano-Ispízua A; Rozman C; Vives Corrons JL
    Sangre (Barc); 1993 Dec; 38(6):481-4. PubMed ID: 8171383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergy among erythropoietin, interleukin 3, stem cell factor (c-kit ligand) and interferon-gamma on early human hematopoiesis.
    Kawano Y; Takaue Y; Hirao A; Sato J; Abe T; Suzue T; Saito S; Okamoto Y; Kuroda Y
    Stem Cells; 1994 Sep; 12(5):514-20. PubMed ID: 7528591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality assurance of CFU-GM assays: inter-laboratory variation despite standard reagents.
    Lumley MA; Burton A; Billingham LJ; McDonald DF; Czarnecka HM; Milligan DW
    Eur J Haematol; 1999 Jan; 62(1):32-7. PubMed ID: 9918309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
    Simmons PJ; Aylett GW; Niutta S; To LB; Juttner CA; Ashman LK
    Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standardization of the CFU-GM assay using hematopoietic growth factors.
    Lewis ID; Rawling T; Dyson PG; Haylock DN; Juttner CA; To LB
    J Hematother; 1996 Dec; 5(6):625-30. PubMed ID: 9117251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution: differences between peripheral blood stem cell and bone marrow recipients.
    Bentley SA; Brecher ME; Powell E; Serody JS; Wiley JM; Shea TC
    Bone Marrow Transplant; 1997 Mar; 19(6):557-63. PubMed ID: 9085735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.